Cargando…
Analyzing a Cost-Effectiveness Dataset: A Speech and Language Example for Clinicians
Cost-effectiveness analysis, the most common type of economic evaluation, estimates a new option's additional outcome in relation to its extra costs. This is crucial to study within the clinical setting because funding for new treatments and interventions is often linked to whether there is evi...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Thieme Medical Publishers, Inc.
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300047/ https://www.ncbi.nlm.nih.gov/pubmed/35858609 http://dx.doi.org/10.1055/s-0042-1750347 |
_version_ | 1784751119364259840 |
---|---|
author | Hoch, Jeffrey S. Haynes, Sarah C. Hearney, Shannon M. Dewa, Carolyn S. |
author_facet | Hoch, Jeffrey S. Haynes, Sarah C. Hearney, Shannon M. Dewa, Carolyn S. |
author_sort | Hoch, Jeffrey S. |
collection | PubMed |
description | Cost-effectiveness analysis, the most common type of economic evaluation, estimates a new option's additional outcome in relation to its extra costs. This is crucial to study within the clinical setting because funding for new treatments and interventions is often linked to whether there is evidence showing they are a good use of resources. This article describes how to analyze a cost-effectiveness dataset using the framework of a net benefit regression. The process of creating estimates and characterizing uncertainty is demonstrated using a hypothetical dataset. The results are explained and illustrated using graphs commonly employed in cost-effectiveness analyses. We conclude with a call to action for researchers to do more person-level cost-effectiveness analysis to produce evidence of the value of new treatments and interventions. Researchers can utilize cost-effectiveness analysis to compare new and existing treatment mechanisms. |
format | Online Article Text |
id | pubmed-9300047 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Thieme Medical Publishers, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93000472022-07-21 Analyzing a Cost-Effectiveness Dataset: A Speech and Language Example for Clinicians Hoch, Jeffrey S. Haynes, Sarah C. Hearney, Shannon M. Dewa, Carolyn S. Semin Speech Lang Cost-effectiveness analysis, the most common type of economic evaluation, estimates a new option's additional outcome in relation to its extra costs. This is crucial to study within the clinical setting because funding for new treatments and interventions is often linked to whether there is evidence showing they are a good use of resources. This article describes how to analyze a cost-effectiveness dataset using the framework of a net benefit regression. The process of creating estimates and characterizing uncertainty is demonstrated using a hypothetical dataset. The results are explained and illustrated using graphs commonly employed in cost-effectiveness analyses. We conclude with a call to action for researchers to do more person-level cost-effectiveness analysis to produce evidence of the value of new treatments and interventions. Researchers can utilize cost-effectiveness analysis to compare new and existing treatment mechanisms. Thieme Medical Publishers, Inc. 2022-07-20 /pmc/articles/PMC9300047/ /pubmed/35858609 http://dx.doi.org/10.1055/s-0042-1750347 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited. |
spellingShingle | Hoch, Jeffrey S. Haynes, Sarah C. Hearney, Shannon M. Dewa, Carolyn S. Analyzing a Cost-Effectiveness Dataset: A Speech and Language Example for Clinicians |
title | Analyzing a Cost-Effectiveness Dataset: A Speech and Language Example for Clinicians |
title_full | Analyzing a Cost-Effectiveness Dataset: A Speech and Language Example for Clinicians |
title_fullStr | Analyzing a Cost-Effectiveness Dataset: A Speech and Language Example for Clinicians |
title_full_unstemmed | Analyzing a Cost-Effectiveness Dataset: A Speech and Language Example for Clinicians |
title_short | Analyzing a Cost-Effectiveness Dataset: A Speech and Language Example for Clinicians |
title_sort | analyzing a cost-effectiveness dataset: a speech and language example for clinicians |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300047/ https://www.ncbi.nlm.nih.gov/pubmed/35858609 http://dx.doi.org/10.1055/s-0042-1750347 |
work_keys_str_mv | AT hochjeffreys analyzingacosteffectivenessdatasetaspeechandlanguageexampleforclinicians AT haynessarahc analyzingacosteffectivenessdatasetaspeechandlanguageexampleforclinicians AT hearneyshannonm analyzingacosteffectivenessdatasetaspeechandlanguageexampleforclinicians AT dewacarolyns analyzingacosteffectivenessdatasetaspeechandlanguageexampleforclinicians |